Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
Celgene
University of California, Davis
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Heinrich-Heine University, Duesseldorf
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Case Comprehensive Cancer Center
Sunnybrook Health Sciences Centre
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seagen Inc.